Cefuroxime: Difference between revisions

From IDWiki
(Created page with "== Background == * Second-generation cephalosporin * Spectrum includes MSSA, streptococci, Haemophilus influenzae, Moraxella catarrhalis, Neisseria meningi...")
 
No edit summary
 
Line 2: Line 2:


* Second-generation [[Cephalosporins|cephalosporin]]
* Second-generation [[Cephalosporins|cephalosporin]]
* Spectrum includes MSSA, streptococci, Haemophilus influenzae, Moraxella catarrhalis, Neisseria meningitides, Neisseria gonorrhoeae, and Escherichia coli
* Spectrum includes [[MSSA]], [[streptococci]], [[Haemophilus influenzae]], [[Moraxella catarrhalis]], [[Neisseria meningitides]], [[Neisseria gonorrhoeae]], and [[Escherichia coli]]
* Time-dependent killing
* Time-dependent killing
* Time to peak 3 hours, elimination half-life 1.2 hours
* Time to peak 3 hours, elimination half-life 1.2 hours
Line 11: Line 11:
* AECOPD: 250 to 500 mg PO q12h for 10 days
* AECOPD: 250 to 500 mg PO q12h for 10 days
* Uncomplicated UTI: 125 to 250 mg PO q12h for 7 to 10 days
* Uncomplicated UTI: 125 to 250 mg PO q12h for 7 to 10 days
* Gonorrhea: 1 g PO once
* [[Gonorrhea]]: 1 g PO once
* Pneumonia: 750 to 1500 mg IV/IM q8h
* Pneumonia: 750 to 1500 mg IV/IM q8h
* Bone or joint infection: 1.5 g IV/IM q8h
* Bone or joint infection: 1.5 g IV/IM q8h

Latest revision as of 19:09, 31 January 2024

Background

Dosing

  • Typical dose: 250 to 500 mg PO q12h
  • AECOPD: 250 to 500 mg PO q12h for 10 days
  • Uncomplicated UTI: 125 to 250 mg PO q12h for 7 to 10 days
  • Gonorrhea: 1 g PO once
  • Pneumonia: 750 to 1500 mg IV/IM q8h
  • Bone or joint infection: 1.5 g IV/IM q8h